These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 37264496)

  • 41. Psychologic disorders and statin use: a propensity score-matched analysis.
    Mansi I; Frei CR; Pugh MJ; Mortensen EM
    Pharmacotherapy; 2013 Jun; 33(6):615-26. PubMed ID: 23625731
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluating the performance of temporal pattern discovery: new application using statins and rhabdomyolysis in OMOP databases.
    Lavallee M; Yu T; Evans L; Van Hemelrijck M; Bosco C; Golozar A; Asiimwe A
    BMC Med Inform Decis Mak; 2022 Feb; 22(1):31. PubMed ID: 35115001
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Safety of a fixed-dose combination of fenofibrate/pravastatin 160 mg/40 mg in patients with mixed hyperlipidaemia: a pooled analysis from a database of clinical trials.
    Farnier M; Marcereuil D; De Niet S; Ducobu J; Steinmetz A; Retterstøl K; Bryniarski L; Császár A; Vanderbist F
    Clin Drug Investig; 2012 Apr; 32(4):281-91. PubMed ID: 22350498
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A survey of the FDA's AERS database regarding muscle and tendon adverse events linked to the statin drug class.
    Hoffman KB; Kraus C; Dimbil M; Golomb BA
    PLoS One; 2012; 7(8):e42866. PubMed ID: 22936996
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Early detection of pharmacovigilance signals with automated methods based on false discovery rates: a comparative study.
    Ahmed I; Thiessard F; Miremont-Salamé G; Haramburu F; Kreft-Jais C; Bégaud B; Tubert-Bitter P
    Drug Saf; 2012 Jun; 35(6):495-506. PubMed ID: 22612853
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A Bayesian neural network method for adverse drug reaction signal generation.
    Bate A; Lindquist M; Edwards IR; Olsson S; Orre R; Lansner A; De Freitas RM
    Eur J Clin Pharmacol; 1998 Jun; 54(4):315-21. PubMed ID: 9696956
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Statin safety: an appraisal from the adverse event reporting system.
    Davidson MH; Clark JA; Glass LM; Kanumalla A
    Am J Cardiol; 2006 Apr; 97(8A):32C-43C. PubMed ID: 16581327
    [TBL] [Abstract][Full Text] [Related]  

  • 48. EU-ADR healthcare database network vs. spontaneous reporting system database: preliminary comparison of signal detection.
    Trifirò G; Patadia V; Schuemie MJ; Coloma PM; Gini R; Herings R; Hippisley-Cox J; Mazzaglia G; Giaquinto C; Scotti L; Pedersen L; Avillach P; Sturkenboom MC; van der Lei J; Eu-Adr Group
    Stud Health Technol Inform; 2011; 166():25-30. PubMed ID: 21685607
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Statin-associated muscular and renal adverse events: data mining of the public version of the FDA adverse event reporting system.
    Sakaeda T; Kadoyama K; Okuno Y
    PLoS One; 2011; 6(12):e28124. PubMed ID: 22205938
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A tree-based scan statistic for zero-inflated count data in post-market drug safety surveillance.
    Park G; Jung I
    Sci Rep; 2022 Sep; 12(1):16299. PubMed ID: 36175526
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association of Statin Use with Increased Risk of Musculoskeletal Conditions: A Retrospective Cohort Study.
    Makris UE; Alvarez CA; Mortensen EM; Mansi IA
    Drug Saf; 2018 Oct; 41(10):939-950. PubMed ID: 29797239
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Post-marketing surveillance study on influenza vaccine in South Korea using a nationwide spontaneous reporting database with multiple data mining methods.
    Lee H; Hong B; Kim S; Kim JH; Choi NK; Jung SY; Shin JY
    Sci Rep; 2022 Nov; 12(1):20256. PubMed ID: 36424402
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An evaluation of a data mining signal for amyotrophic lateral sclerosis and statins detected in FDA's spontaneous adverse event reporting system.
    Colman E; Szarfman A; Wyeth J; Mosholder A; Jillapalli D; Levine J; Avigan M
    Pharmacoepidemiol Drug Saf; 2008 Nov; 17(11):1068-76. PubMed ID: 18821724
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Novel methods for pregnancy drug safety surveillance in the FDA Sentinel System.
    Suarez EA; Nguyen M; Zhang D; Zhao Y; Stojanovic D; Munoz M; Liedtka J; Anderson A; Liu W; Dashevsky I; Cole D; DeLuccia S; Menzin T; Noble J; Maro JC
    Pharmacoepidemiol Drug Saf; 2023 Feb; 32(2):126-136. PubMed ID: 35871766
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Detection of statin-induced rhabdomyolysis and muscular related adverse events through data mining technique.
    Kunakorntham P; Pattanaprateep O; Dejthevaporn C; Thammasudjarit R; Thakkinstian A
    BMC Med Inform Decis Mak; 2022 Sep; 22(1):233. PubMed ID: 36064346
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Preventable statin adverse reactions and therapy discontinuation. What can we learn from the spontaneous reporting system?
    Sessa M; Rafaniello C; Scavone C; Mascolo A; di Mauro G; Fucile A; Rossi F; Sportiello L; Capuano A
    Expert Opin Drug Saf; 2018 May; 17(5):457-465. PubMed ID: 29619841
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Useful Interplay Between Spontaneous ADR Reports and Electronic Healthcare Records in Signal Detection.
    Pacurariu AC; Straus SM; Trifirò G; Schuemie MJ; Gini R; Herings R; Mazzaglia G; Picelli G; Scotti L; Pedersen L; Arlett P; van der Lei J; Sturkenboom MC; Coloma PM
    Drug Saf; 2015 Dec; 38(12):1201-10. PubMed ID: 26370104
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characterization of Statin-Associated Myopathy Case Reports in Thailand Using the Health Product Vigilance Center Database.
    Boonmuang P; Nathisuwan S; Chaiyakunapruk N; Suwankesawong W; Pokhagul P; Teerawattanapong N; Supsongserm P
    Drug Saf; 2013 Sep; 36(9):779-87. PubMed ID: 23615756
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A real-world pharmacovigilance study of abaloparatide based on the FDA Adverse Event Reporting System (FAERS).
    Shi X; Cheng Q; Zhao YZ; Zou SP; Sun MH
    Osteoporos Int; 2023 Dec; 34(12):2047-2058. PubMed ID: 37594595
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An Automated System Combining Safety Signal Detection and Prioritization from Healthcare Databases: A Pilot Study.
    Arnaud M; Bégaud B; Thiessard F; Jarrion Q; Bezin J; Pariente A; Salvo F
    Drug Saf; 2018 Apr; 41(4):377-387. PubMed ID: 29185236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.